The medtech segment achieved operational revenue growth of 4.4% despite ongoing weaknesses in the Chinese market. Notably, ...
Johnson & Johnson is collating its pantheon of medtech brands under a single banner, to further simplify the company’s ...
More than a decade after taking on Johnson & Johnson with the first trial linking baby powder to ovarian cancer, attorney ...
Johnson & Johnson (NYSE:JNJ) is currently experiencing a mix of robust growth and notable challenges. Recent developments ...
In a report released yesterday, Shagun Singh Chadha from RBC Capital maintained a Buy rating on Johnson & Johnson (JNJ – Research ...
A state judge in Oregon has overturned a $260 million verdict against Johnson & Johnson in a mesothelioma lawsuit. The judge ...
Dakota Johnson is no stranger to the sheer dress trend. In fact, it’s practically her red carpet signature at this point. If ...
In a report released today, Joanne Wuensch from Citi reiterated a Buy rating on Johnson & Johnson (JNJ – Research Report). The ...
12hon MSN
For her part, Daisy was rocking a textured, white, see-through crop top and matching shorts paired with a matching jacket, oversized slouchy brown bag, pearl necklace and a pair of brown suede flats ...
Johnson & Johnson (JNJ) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback